Literature DB >> 27241966

Endocrine Dysfunction in X-Linked Adrenoleukodystrophy.

Elizabeth Burtman1, Molly O Regelmann2.   

Abstract

X-linked adrenoleukodystrophy (X-ALD) is caused by mutations in the ABCD1 gene and leads to an elevation of very-long-chain fatty acids (VLCFA). The accumulation of the VLCFA and the associated oxidative stress can present with a spectrum of significant neurologic disease, adrenal insufficiency, and testicular dysfunction in males with ABCD1 gene mutations. Much of the published literature for X-ALD has focused on the associated devastating progressive neurologic conditions. The purpose of this review is to summarize the concerns for endocrine dysfunction associated with X-ALD and provide guidance for monitoring and management of adrenal insufficiency.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ABCD1; Addison disease; Adrenal insufficiency; Adrenomyeloneuropathy; Androgen deficiency; Testicular dysfunction; Very-long-chain fatty acids; X-linked adrenoleukodystrophy

Mesh:

Substances:

Year:  2016        PMID: 27241966     DOI: 10.1016/j.ecl.2016.01.003

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  14 in total

1.  A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination.

Authors:  Lauren R Strachan; Tamara J Stevenson; Briana Freshner; Matthew D Keefe; D Miranda Bowles; Joshua L Bonkowsky
Journal:  Hum Mol Genet       Date:  2017-09-15       Impact factor: 6.150

2.  DISCOVERY OF FUNCTIONAL AND DISEASE PATHWAYS BY COMMUNITY DETECTION IN PROTEIN-PROTEIN INTERACTION NETWORKS.

Authors:  Stephen J Wilson; Angela D Wilkins; Chih-Hsu Lin; Rhonald C Lua; Olivier Lichtarge
Journal:  Pac Symp Biocomput       Date:  2017

Review 3.  Bilateral testicular masses and adrenal insufficiency: is congenital adrenal hyperplasia the only possible diagnosis? First two cases of TARTS described in Addison-only X-linked adrenoleukodystrophy and a brief review of literature.

Authors:  A S Tresoldi; N Betella; V Hasenmajer; C Pozza; W Vena; B Fiamengo; L Negri; M Cappa; A G A Lania; A Lenzi; A M Isidori; A Pizzocaro
Journal:  J Endocrinol Invest       Date:  2020-07-20       Impact factor: 4.256

Review 4.  Epidemiology, pathogenesis, and diagnosis of Addison's disease in adults.

Authors:  C Betterle; F Presotto; J Furmaniak
Journal:  J Endocrinol Invest       Date:  2019-07-18       Impact factor: 5.467

Review 5.  X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies.

Authors:  Bela R Turk; Christiane Theda; Ali Fatemi; Ann B Moser
Journal:  Int J Dev Neurosci       Date:  2020-01-26       Impact factor: 2.457

6.  Primary adrenal insufficiency in two siblings with D-bifunctional protein deficiency.

Authors:  Cristel C Chapel-Crespo; Ricardo Villalba; Raymond Wang; Monica Boyer; Richard Chang; Hans R Waterham; Jose E Abdenur
Journal:  Mol Genet Metab Rep       Date:  2020-06-05

7.  X-LINKED ADRENOLEUKODYSTROPHY IN BRAZIL: A CASE SERIES.

Authors:  Fernanda Luiza Schumacher Furlan; Macleise Andres Lemes; Ligia Cecilia Fuverki Suguimatsu; Carolina Teixeira Furquim Pires; Mara Lucia Schmitz Ferreira Santos
Journal:  Rev Paul Pediatr       Date:  2019-06-19

8.  Adrenoleukodystrophy in the Differential Diagnosis of Boys Presenting with Primary Adrenal Insufficiency without Adrenal Antibodies

Authors:  Michael R. Ryalls; Hoong-Wei Gan; James E. Davison
Journal:  J Clin Res Pediatr Endocrinol       Date:  2020-05-12

9.  S149R, a novel mutation in the ABCD1 gene causing X-linked adrenoleukodystrophy.

Authors:  Fang Yan; Wenbo Wang; Hui Ying; Hongyu Li; Jing Chen; Chao Xu
Journal:  Oncotarget       Date:  2017-09-18

10.  Adult-Onset Cerebral Adrenoleukodystrophy Without Adrenal Gland Involvement.

Authors:  Aniruddh Mannari; Brandon Wiggins; Ghassan Bachuwa
Journal:  Cureus       Date:  2020-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.